COMMUNIQUÉS West-GlobeNewswire

Spectral AI Schedules 2026 First Quarter Financial Results and Conference Call
28/04/2026
DALLAS, April 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate [...]
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026
28/04/2026
DURHAM, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for [...]
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026
Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today Strongly Opposes the Election of Each of DOMA’s Underqualified Nominees BRISBANE, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28/04/2026
If approved, ReNu® will revolutionize treatment options for millions of patients with knee OA pain CANTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative [...]
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026
North Florida's Leading Dental Provider Offers an Increased Number of Procedures Across All Locations Jacksonville, FL, April 28, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a cornerstone of the Jacksonville healthcare [...]
Glass House Brands Reports Preliminary Unaudited First Quarter Financial Results, Updates FY2026 Guidance and Schedules Earnings Conference Call
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced preliminary and unaudited [...]
Glass House Brands Announces Warrant Redemption Notice
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced that it has delivered a [...]
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026
Assemblée générale 2026 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 4,00 € par action, avec possibilité de choisir un versement en actions Paris, France (28 [...]
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 4.00 per share, with option for payment in shares Paris, France (28 April 2026 – 6:00 pm [...]
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenita Study Will be Led [...]
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026
Au Spanish Congress of Deputies (Congrès des députés espagnol), María Torres la Présidente de l’EAACI, a apporté son soutien à un manifeste commun rédigé avec l’AEPNAA, la SEAIC et la SEICAP, appelant à une action [...]
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026
Agency unveils real-time trial proofs-of-concept and upcoming pilot program White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an [...]
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026
Contribution will support multi-stakeholder efforts to strengthen the use of patient experience data in healthcare decision-making FRAMINGHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Alira Health today announced its [...]
Aeroflow Health Applauds Georgia Medicaid’s New Telehealth Lactation Coverage
28/04/2026
Georgia Medicaid members now have access to telehealth lactation services, following sustained advocacy efforts led by Aeroflow and the American Telemedicine Association ASHEVILLE, N.C., April 28, 2026 (GLOBE NEWSWIRE [...]
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies
28/04/2026
Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target Large, Underserved Osteoarthritis Market PHOENIX, April 28, 2026 (GLOBE NEWSWIRE) -- Creative Medical [...]
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026
Latest authorization expands MiniMed CGM portfolio in Canada BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health [...]
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin’s 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group Neuroimaging data [...]
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
28/04/2026
Oslo, Norway, 28 April 2026 Vistin Pharma ASA (OSE: VISTN); please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 20 May 2026 at 13:00 CEST. It will not be possible with physical [...]

Pages